Broad immune cell populations via secreted cytokines and extracellular vesicles

The term "Broad immune cell populations via secreted cytokines and extracellular vesicles" refers to a complex physiological communication network rather than a single molecular target. This network facilitates the coordinated regulation of various immune cells, such as T cells, B cells, and myeloid cells, through two primary mediators: secreted cytokines and extracellular vesicles (EVs). Cytokines are small signaling proteins that bind to specific cell-surface receptors to induce immediate functional changes (NIH/NCBI, 2023), while EVs, including exosomes and microvesicles, serve as sophisticated transport vehicles for proteins, lipids, and nucleic acids, enabling long-range and multi-component signaling (Nature Reviews Molecular Cell Biology, 2018). In therapeutic development, this system is frequently leveraged by cell-based therapies, such as mesenchymal stem cells (MSCs), which utilize their "secretome" to modulate inflammatory environments and promote tissue regeneration (Journal of Extracellular Vesicles, 2019). Because this entry encompasses a vast array of distinct molecular entities and cell types, it is classified as a biological mechanism or systemic effect rather than a discrete, druggable therapeutic target.

Other names

Immune cell secretomeParacrine immune signaling networkEV-mediated immune modulationCytokine-mediated intercellular communication

Modulation of diverse immune cell phenotypes through the paracrine and systemic delivery of signaling proteins (cytokines) and membrane-bound particles (extracellular vesicles) containing bioactive cargo.